These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27358992)

  • 1. [Domestication of suspension CHO cells and its application in the expression of anti-PSMA antibody].
    Wu J; Han D; Wei M; Zheng G; Jiao D; Xi W; Yang A; Qin W; Wen W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jan; 32(1):1-4. PubMed ID: 27358992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-prostate specific membrane antigen designer T cells for prostate cancer therapy.
    Ma Q; Safar M; Holmes E; Wang Y; Boynton AL; Junghans RP
    Prostate; 2004 Sep; 61(1):12-25. PubMed ID: 15287090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabody.
    Fortmüller K; Alt K; Gierschner D; Wolf P; Baum V; Freudenberg N; Wetterauer U; Elsässer-Beile U; Bühler P
    Prostate; 2011 May; 71(6):588-96. PubMed ID: 20945402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the optimal ratio of heavy to light chain genes for efficient recombinant antibody production by CHO cells.
    Schlatter S; Stansfield SH; Dinnis DM; Racher AJ; Birch JR; James DC
    Biotechnol Prog; 2005; 21(1):122-33. PubMed ID: 15903249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSMA specific single chain antibody-mediated targeted knockdown of Notch1 inhibits human prostate cancer cell proliferation and tumor growth.
    Su Y; Yu L; Liu N; Guo Z; Wang G; Zheng J; Wei M; Wang H; Yang AG; Qin W; Wen W
    Cancer Lett; 2013 Sep; 338(2):282-91. PubMed ID: 23752065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel anti-PSMA human scFv has the potential to be used as a diagnostic tool in prostate cancer.
    Han D; Wu J; Han Y; Wei M; Han S; Lin R; Sun Z; Yang F; Jiao D; Xie P; Zhang L; Yang AG; Zhao A; Wen W; Qin W
    Oncotarget; 2016 Sep; 7(37):59471-59481. PubMed ID: 27448970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rapid construction of a mammalian cell surface display library of full-length human antibodies].
    He W; Li CZ; Chen ZR; Zhou Y; Tan WL; Jiang SB; Zhou ZG; Liu SW; Zhou C
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):308-12. PubMed ID: 21354918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of structural variations on biological activity of anti-PSMA scFv and immunotoxins targeting prostate cancer.
    Bühler P; Wetterauer D; Gierschner D; Wetterauer U; Beile UE; Wolf P
    Anticancer Res; 2010 Sep; 30(9):3373-9. PubMed ID: 20944111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging.
    Frigerio B; Franssen G; Luison E; Satta A; Seregni E; Colombatti M; Fracasso G; Valdagni R; Mezzanzanica D; Boerman O; Canevari S; Figini M
    Oncotarget; 2017 Feb; 8(7):10919-10930. PubMed ID: 28051996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple method to determine IgG light chain to heavy chain polypeptide ratios expressed by CHO cells.
    Gerster A; Wodarczyk C; Reichenbächer B; Köhler J; Schulze A; Krause F; Müller D
    Biotechnol Lett; 2016 Dec; 38(12):2043-2049. PubMed ID: 27613153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of chimeric anti-CD3 IgG antibody in mammalian cells and analysis of its biological activity].
    Shao XF; Xu C; Xu YF; Xiong DS; Liu YX; Yang CZ
    Sheng Wu Gong Cheng Xue Bao; 2003 Sep; 19(5):527-31. PubMed ID: 15969078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Camel heavy chain antibodies against prostate-specific membrane antigen.
    Evazalipour M; Tehrani BS; Abolhassani M; Morovvati H; Omidfar K
    Hybridoma (Larchmt); 2012 Dec; 31(6):424-9. PubMed ID: 23244321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable expression of a recombinant human antinucleosome antibody to investigate relationships between antibody sequence, binding properties, and pathogenicity.
    Mason LJ; Lambrianides A; Haley JD; Manson JJ; Latchman DS; Isenberg DA; Rahman A
    Arthritis Res Ther; 2005; 7(5):R971-83. PubMed ID: 16207338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of radiochemical modification on biodistribution of scFvD2B antibody fragment recognising prostate specific membrane antigen.
    Frigerio B; Benigni F; Luison E; Seregni E; Pascali C; Fracasso G; Morlino S; Valdagni R; Mezzanzanica D; Canevari S; Figini M
    Immunol Lett; 2015 Nov; 168(1):105-10. PubMed ID: 26404855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of a recombinant anti-prostate specific membrane antigen single-chain immunotoxin against prostate cancer.
    Wolf P; Alt K; Wetterauer D; Bühler P; Gierschner D; Katzenwadel A; Wetterauer U; Elsässer-Beile U
    J Immunother; 2010 Apr; 33(3):262-71. PubMed ID: 20445346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Construction, expression, and identification of the gene of human anti-prostate specific membrane antigen single-chain antibody].
    Su YS; Fu XL; Wang D; Wang QY; Liu N; Jia HB; Qin WJ; Wen WH; Wang H
    Zhonghua Nan Ke Xue; 2014 Dec; 20(12):1063-7. PubMed ID: 25597169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 99mTc-labelled scFv antibody fragment that binds to prostate-specific membrane antigen.
    Nawaz S; Mullen GED; Blower PJ; Ballinger JR
    Nucl Med Commun; 2017 Aug; 38(8):666-671. PubMed ID: 28598898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction of dengue virus-specific full-length fully human antibody libraries by mammalian display technology].
    Wen Y; Lan K; Wang J; Yu J; Qu Y; Zhao W; Zhang F; Tan W; Cao H; Zhou C
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):847-52. PubMed ID: 23803195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer.
    Elsässer-Beile U; Wolf P; Gierschner D; Bühler P; Schultze-Seemann W; Wetterauer U
    Prostate; 2006 Sep; 66(13):1359-70. PubMed ID: 16894535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, production, and characterization of a single-chain variable fragment (ScFv) derived from the prostate specific membrane antigen (PSMA) monoclonal antibody J591.
    Parker SA; Diaz IL; Anderson KA; Batt CA
    Protein Expr Purif; 2013 Jun; 89(2):136-45. PubMed ID: 23500147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.